Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
FertyBiotic Balance is an oral probiotic dietary supplement developed by Fertypharm, S.L., a Spanish fertility-oriented company. It is formulated to support reproductive health by promoting a healthy microbial balance in the vaginal and endometrial tracts, which is essential for successful embryo implantation and fertility. The product contains three specific probiotic strains—*Lactobacillus rhamnosus* BPL205, *Lactobacillus plantarum* BPL207, and *Lactobacillus crispatus* BPL209—in combination with Vitamin D (cholecalciferol). It is designed to be taken daily throughout the fertility cycle to provide probiotic reinforcement and support the physiological conditions necessary for pregnancy. The formulation is vegan, lactose-free, and gluten-free.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on FertyBiotic Balance.